Pay in 4 interest-free payments of $6.82 Learn more
Ships within 48 hours Β· Estimated delivery Aug 12 - Aug 17
Semaglutide, the first dedicated GLP-1 obesity treatment, achieved 14.9% body weight reduction in the STEP 1 trial
Description Overview AOD-9604 is a synthetic peptide fragment derived from the C-terminal region of human growth hormone and is widely referenced in research on adipose tissue metabolism, lipolysis and body-composition management models
Will I get what I see in the picture
A 140-lb user takes the same BPC-157 dose as a 220-lb user
10 mg equals 10,000 mcg 10,000 mcg / 2 mL = 5,000 mcg per mL 2,500 mcg / 5,000 mcg per mL = 0.5 mL Tirzepatide 10 mg vial with 2 mL example A 10 mg tirzepatide vial mixed with 2 mL gives 5 mg/mL, or 5,000 mcg/mL
Third-party COA available showing 98% or higher purity Independent laboratory verification (not just manufacturer claims) HPLC (High Performance Liquid Chromatography) testing documentation Mass spectrometry confirmation of correct molecular weight Endotoxin testing results within acceptable limits Established vendor reputation with positive community feedback Proper packaging protecting peptide from light and moisture Cold shipping available for warm weather deliveries Warning signs of questionable sources include suspiciously low prices, absence of testing documentation, unclear manufacturing origins, and vendors who cannot answer basic questions about their products
US$ 20.84
US$ 25.75
US$ 29.14
